VERONA PHARMA PLC's ticker is VRNA and the CUSIP is 925050106. A total of 37 filers reported holding VERONA PHARMA PLC in Q4 2020. The put-call ratio across all filers is 1.20 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,429,461 | +7.8% | 87,697 | +39.8% | 0.00% | – |
| Q2 2023 | $1,326,048 | -14.9% | 62,727 | -19.2% | 0.00% | – |
| Q1 2023 | $1,558,309 | +45.8% | 77,605 | +89.7% | 0.00% | – |
| Q4 2022 | $1,068,691 | +7533.5% | 40,899 | +2863.7% | 0.00% | – |
| Q3 2022 | $14,000 | +100.0% | 1,380 | -17.7% | 0.00% | – |
| Q2 2022 | $7,000 | +133.3% | 1,677 | +181.8% | 0.00% | – |
| Q1 2022 | $3,000 | -57.1% | 595 | -40.0% | 0.00% | – |
| Q4 2021 | $7,000 | -88.3% | 992 | -91.0% | 0.00% | – |
| Q3 2021 | $60,000 | +172.7% | 11,070 | +230.0% | 0.00% | – |
| Q2 2021 | $22,000 | +633.3% | 3,355 | +724.3% | 0.00% | – |
| Q4 2020 | $3,000 | – | 407 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 2,457,499 | $16,932,000 | 5.79% |
| Aisling Capital Management LP | 1,332,485 | $9,327,000 | 1.60% |
| Ghost Tree Capital, LLC | 810,000 | $5,670,000 | 1.26% |
| Vivo Capital, LLC | 3,048,507 | $21,340,000 | 0.95% |
| NEA Management Company, LLC | 5,108,563 | $35,760,000 | 0.94% |
| Novo Holdings A/S | 2,608,755 | $18,261,000 | 0.78% |
| Samsara BioCapital, LLC | 1,111,112 | $7,778,000 | 0.78% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,033,603 | $7,235,000 | 0.64% |
| RA Capital Management | 5,100,000 | $31,824,000 | 0.44% |
| Orbimed Advisors | 5,694,841 | $39,864,000 | 0.35% |